Kei F. Carver Wong

Kei F. Carver Wong

Auto-generated profile, based on publicly available information

Kei F. Carver Wong

Centre for Analytical Bioscience, Advanced Materials & Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in Essays in Biochemistry
Verified
Journal Article
Open access
PDF file
KWKei F. Carver Wong
Kei F. Carver Wong
RGRebecca E. Greatorex
Rebecca E. Greatorex
CGCharlotte E. Gidman
Charlotte E. Gidman
SRSidrah Rahman
Sidrah Rahman
RGRian L. Griffiths
Rian L. Griffiths
This review aims to summarise the current capabilities of surface mass spectrometry (MS) approaches that offer intact protein analysis, and that of non-covalent complexes. Protein analysis is largely achieved via matrix-assisted laser desorption/ionisation (MALDI), which is in itself a surface analysis approach or solvent-based electrospray ionisation (ESI). Several surface sampling approaches have been developed based on ESI, and those that have been used for intact protein analysis will be discussed below. The extent of protein coverage, top-down elucidation, and probing of protein structure for native proteins and non-covalent complexes will be discussed for each approach. Strategies for improving protein analysis, ranging from sample preparation, and sampling methods to instrument modifications and the inclusion of ion mobility separation in the workflow will also be discussed. The relative benefits and drawbacks of each approach will be summarised, providing an overview of current capabilities.

31 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
QDQiran Du
Qiran Du
KMKimberly Mace
Kimberly Mace
KWKei F.C. Wong
Kei F.C. Wong
KLKaren Lawler
Karen Lawler
AKAnna Kotowska
Anna Kotowska
AGAmir M. Ghaemmaghami
Amir M. Ghaemmaghami
Macrophages and fibroblasts play central roles in coordinating inflammation and tissue repair, whilst dysregulation of macrophage-fibroblast crosstalk drives pathological outcomes such as chronic inflammation and fibrosis. Glycosaminoglycans (GAGs), key components of the extracellular matrix (ECM), interact with cytokines and growth factors that modulate macrophage polarisation and direct fibroblast activity, making them attractive candidates for developing immune-instructive biomaterials. However, the optimal GAG compositions that promote macrophage-mediated repair and fibroblast-driven ECM remodelling remain unclear. Here, we report an unbiased screening of 82 surface-adsorbed GAG combinations to identify candidates capable of modulating macrophage-fibroblast interactions. Leveraging cytokine profiling, surface marker immunostaining, gene expression, principal component analysis (PCA), and hierarchical clustering, we identified ’hit’ GAG combinations that induced distinct, non-canonical macrophage activation programmes characterised by coordinated inflammatory and regulatory signalling, alongside enhanced fibroblast proliferation. Shortlisted formulations were validated using expanded biological replication, orthogonal phenotypic, transcriptional and functional analyses, assessment in macrophage-fibroblast co-culture systems, and in an in vivo diabetic wound model. These data demonstrated that 'hit' GAG formulations modulated macrophage functional activation states, promoted collagen and ECM synthesis, facilitated vascular and lymphatic vessel formation, and accelerated wound closure. Complementary metabolomic profiling using OrbiSIMS and molecular formula prediction (MFP), revealed macrophage metabolic reprogramming as a potential mechanism underlying these pro-healing effects. Collectively, this study established an unbiased methodology for discovering immune-instructive GAGs in supporting pro-healing responses for potential wound-healing applications.Keywords: Glycosaminoglycans; Macrophage-fibroblast crosstalk; Immunomodulation; Diabetic wound healing; Combinatorial screening; OrbiSIMS metabolomics

17 October 2025 in Analytica Chimica Acta
Verified
Journal Article
Open access
KKKyeong Seog Kim
Kyeong Seog Kim
KWKei F. Carver Wong
Kei F. Carver Wong
AJAra Jo
Ara Jo
SMSandra Martínez-Jarquín
Sandra Martínez-Jarquín
RJRakesh Jha
Rakesh Jha
Joo-Youn ChoJoo-Youn Cho
Joo-Youn Cho
The commensal nasal microbiota Staphylococcus epidermidis (S. epidermidis) can suppress influenza A virus (IAV) activity in the host lung by modulating the microcellular environment. However, the metabolic mechanisms underlying this antiviral effect remain unclear. This study employs a novel combination of atmospheric pressure matrix-assisted laser desorption/ionization (AP-MALDI) and Orbitrap secondary ion mass spectrometry (OrbiSIMS) imaging to investigate the metabolic interactions between nasal microbiota and IAV infection in mouse lung tissue. By utilizing this high-resolution dual-platform MS imaging (MSI) approach, we achieved high spatial resolution mapping of metabolic alterations, revealing polyamine metabolism as a key pathway mediating the antiviral effects of S. epidermidis. Our findings demonstrate that S. epidermidis inoculation downregulates polyamine metabolism, significantly suppressing IAV replication, a mechanism confirmed through targeted polyamine supplementation. Additionally, sulfate/sulfite metabolism was identified as a crucial metabolic pathway modulated in IAV-infected and S. epidermidis-treated lungs. This study represents the first application of integrated AP-MALDI and OrbiSIMS MSI to antiviral metabolomic analysis, providing critical insights into host-microbiota interactions in respiratory infections. Our results provide a foundation for utilizing spatial metabolomics to explore novel therapeutic targets for viral infections and highlight the potential of nasal microbiota in respiratory defense. These findings could advance MS-based biomarker discovery and antiviral drug development.

3 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
KWKei F.C. Wong
Kei F.C. Wong
ZMZsuzsa Markus
Zsuzsa Markus
RGRian L. Griffiths
Rian L. Griffiths
ZZZheying Zhu
Zheying Zhu
MGMarios Georgiou
Marios Georgiou
Existing Drosophila cancer models lack methods for profiling biomolecular changes in tumour regions following anticancer drug treatment. Here, we present a protocol to cryosection an in vivo D. melanogaster pupal cancer model for atmospheric pressure matrix-assisted laser desorption ionisation (AP-MALDI) mass spectrometry (MS) imaging. We describe approaches for conducting high-throughput drug-treatment of fruit flies, performing quantitative confocal imaging, cryosectioning model pupae, and conducting AP-MALDI MS-imaging and metabolomics. This protocol enables spatial profiling of metabolites and lipids in D. melanogaster cancer pupae.